Dana M Brantley-Sieders Selected Research

Ephrin-A1 (Ephrin A1)

1/2020	Host deficiency in ephrin-A1 inhibits breast cancer metastasis.
1/2016	The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
1/2011	Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.
11/2006	Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
11/2005	Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dana M Brantley-Sieders Research Topics

Disease

28	Neoplasms (Cancer) 01/2021 - 04/2004
10	Neoplasm Metastasis (Metastasis) 12/2020 - 11/2005
9	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2008
5	Lung Neoplasms (Lung Cancer) 11/2020 - 01/2009
4	Carcinogenesis 01/2016 - 11/2005
3	Vascular Remodeling 11/2005 - 01/2004
2	Melanoma (Melanoma, Malignant) 01/2009 - 11/2005
2	Adenocarcinoma 01/2008 - 11/2005
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Triple Negative Breast Neoplasms 01/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Inflammation (Inflammations) 01/2009
1	Colonic Neoplasms (Colon Cancer) 11/2005

Drug/Important Bio-Agent (IBA)

9	Phosphotransferases (Kinase)IBA 01/2018 - 01/2004
9	LigandsIBA 12/2017 - 01/2004
8	tyrosine receptor (receptor, tyrosine)IBA 01/2016 - 01/2004
7	EphA2 ReceptorIBA 01/2021 - 11/2005
5	Ephrin-A1 (Ephrin A1)IBA 01/2020 - 11/2005
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2017 - 01/2008
4	EphrinsIBA 02/2012 - 01/2004
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 04/2004
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 01/2018
2	Glutamine (L-Glutamine)FDA Link 12/2017 - 01/2016
2	GlutaminaseIBA 12/2017 - 01/2016
2	GTP Phosphohydrolases (GTPases)IBA 01/2008 - 11/2005
2	EphA1 Receptor (Eph Receptor)IBA 01/2008 - 01/2008
2	Eph Family Receptors (Eph Receptors)IBA 01/2008 - 04/2004
1	Peptides (Polypeptides)IBA 01/2021
1	AntibodiesIBA 01/2021
1	cadherin 5IBA 12/2020
1	Thromboxane Receptors (Thromboxane Receptor)IBA 12/2020
1	Everolimus FDA Link 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	EnzymesIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2018
1	Lapatinib (GW572016)FDA Link 01/2018
1	LipidsIBA 01/2016
1	PlasticsIBA 01/2016
1	matrigelIBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2015
1	ErbB Receptors (EGF Receptor)IBA 07/2015
1	Interleukin-13IBA 11/2014
1	c-Mer Tyrosine KinaseIBA 11/2014
1	Interleukin-4 (Interleukin 4)IBA 11/2014
1	CytokinesIBA 11/2014
1	Interleukin-10 (Interleukin 10)IBA 11/2014
1	ALW-II-41-27IBA 05/2014
1	Adenosine Triphosphate (ATP)IBA 05/2014
1	EphA3 ReceptorIBA 08/2012
1	Bromodeoxyuridine (BrdU)IBA 08/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2012
1	Trastuzumab (Herceptin)FDA Link 01/2010
1	Epidermal Growth Factor (EGF)IBA 01/2010
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 05/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	Tyrosine (L-Tyrosine)FDA Link 06/2008
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2008
1	Conditioned Culture MediaIBA 11/2006
1	Small Interfering RNA (siRNA)IBA 11/2006

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2008